Telehealth treatment for alcohol use disorder
A Telehealth Intervention to Increase Screening and Treatment for Alcohol Use Disorder
This study tests a new online treatment program for people with alcohol use disorder to see if it helps them reduce their drinking better than just being on a waiting list.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 124 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Ria Health Industry-sponsored |
| Locations | 1 site (Stanford, California) |
| Trial ID | NCT05747703 on ClinicalTrials.gov |
What this trial studies
This clinical trial involves participants with alcohol use disorder who will be randomly assigned to either the Ria Treatment Platform or a waitlist control. The Ria Treatment Platform utilizes a telehealth approach that includes medical assessments, medications, individual and group coaching, educational video modules, and a Bluetooth-enabled breathalyzer. Participants will be monitored for three months to collect data on their alcohol consumption and its consequences.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals diagnosed with alcohol use disorder.
Not a fit: Patients who are unable to provide informed consent will not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could provide a convenient and effective way for patients to manage and reduce their alcohol use.
How similar studies have performed: Other studies have shown success with telehealth interventions for substance use disorders, indicating a promising approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * alcohol use disorder Exclusion Criteria: * inability to provide informed consent
Where this trial is running
Stanford, California
- Stanford University — Stanford, California, United States (Recruiting)
Study contacts
- Principal investigator: John Mendelson, MD — Ria Health
- Study coordinator: LaTrice Montgomery, Ph.D.
- Email: latrice.montgomery@riahealth.com
- Phone: 513-349-1052
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.